AU2001295672A1 - Vaccine composition and stabilisation method - Google Patents

Vaccine composition and stabilisation method

Info

Publication number
AU2001295672A1
AU2001295672A1 AU2001295672A AU2001295672A AU2001295672A1 AU 2001295672 A1 AU2001295672 A1 AU 2001295672A1 AU 2001295672 A AU2001295672 A AU 2001295672A AU 2001295672 A AU2001295672 A AU 2001295672A AU 2001295672 A1 AU2001295672 A1 AU 2001295672A1
Authority
AU
Australia
Prior art keywords
vaccine composition
stabilisation method
stabilisation
vaccine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001295672A
Other versions
AU2001295672B2 (en
Inventor
Alain Francon
Catherine Noel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Inc
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0012805A external-priority patent/FR2814957B1/en
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of AU2001295672A1 publication Critical patent/AU2001295672A1/en
Assigned to SANOFI PASTEUR reassignment SANOFI PASTEUR Amend patent request/document other than specification (104) Assignors: AVENTIS PASTEUR
Application granted granted Critical
Publication of AU2001295672B2 publication Critical patent/AU2001295672B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001295672A 2000-10-06 2001-10-08 Vaccine composition and stabilisation method Ceased AU2001295672B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0012805A FR2814957B1 (en) 2000-10-06 2000-10-06 VACCINE COMPOSITION AND STABILIZATION METHOD
FR00/12805 2000-10-06
PCT/FR2001/003097 WO2002028362A2 (en) 2000-10-06 2001-10-08 Vaccine composition and stabilisation method

Publications (2)

Publication Number Publication Date
AU2001295672A1 true AU2001295672A1 (en) 2002-06-27
AU2001295672B2 AU2001295672B2 (en) 2005-08-18

Family

ID=8855080

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001295672A Ceased AU2001295672B2 (en) 2000-10-06 2001-10-08 Vaccine composition and stabilisation method
AU9567201A Pending AU9567201A (en) 2000-10-06 2001-10-08 Vaccine composition and stabilisation method

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU9567201A Pending AU9567201A (en) 2000-10-06 2001-10-08 Vaccine composition and stabilisation method

Country Status (12)

Country Link
US (1) US6982088B2 (en)
EP (1) EP1357895A2 (en)
JP (1) JP2004526667A (en)
KR (1) KR100832551B1 (en)
CN (1) CN1298387C (en)
AU (2) AU2001295672B2 (en)
BR (1) BR0114350A (en)
CA (1) CA2424863A1 (en)
FR (1) FR2814957B1 (en)
MX (1) MXPA03002875A (en)
NZ (1) NZ525117A (en)
WO (1) WO2002028362A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007056847A1 (en) * 2005-11-21 2007-05-24 Sanofi Pasteur Limited Stabilizing formulations for recombinant viruses
BR112013005049A2 (en) * 2010-09-02 2016-05-31 Sanofi Pasteur stabilizer for the preparation of an injectable dry polio vaccine composition
US10400029B2 (en) 2011-06-28 2019-09-03 Inhibrx, Lp Serpin fusion polypeptides and methods of use thereof
PL2726092T3 (en) 2011-06-28 2019-11-29 Inhibrx Lp Serpin fusion polypeptides and methods of use thereof
KR20140068861A (en) 2011-06-28 2014-06-09 인히브릭스 엘엘씨 Wap domain fusion polypeptides and methods of use thereof
US9827303B2 (en) * 2012-03-05 2017-11-28 De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport Methods and compositions for stabilizing dried biological materials
SG11201507462QA (en) * 2013-03-14 2015-10-29 Takeda Vaccines Inc Compositions and methods for live, attenuated alphavirus formulations
NL2018155B1 (en) * 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
US20210322542A1 (en) * 2020-04-11 2021-10-21 Qiyi Xie Vaccination against coronavirus with poliomyelitis vaccine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617350C3 (en) * 1967-06-22 1979-09-06 Behringwerke Ag, 3550 Marburg Process for the inactivation of biological material
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US3915764A (en) * 1973-05-18 1975-10-28 Westinghouse Electric Corp Sputtering method for growth of thin uniform layers of epitaxial semiconductive materials doped with impurities
ES2037072T3 (en) * 1986-12-19 1993-06-16 Duphar International Research B.V STABILIZED COADJUVANT SUSPENSION INCLUDING DIMETHYL-DIOCTADECIL-AMMONIUM BROMIDE.
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
CA2075521C (en) * 1992-05-05 1995-11-28 Kuniaki Koyama Stabilized live vaccine
JP3583128B2 (en) * 1993-01-08 2004-10-27 シーエスエル、リミテッド Vaccine preparation
CA2158935A1 (en) * 1993-10-12 1995-04-20 Chiron Viagene, Inc. Methods for preserving recombinant viruses
US6379677B1 (en) * 2000-02-25 2002-04-30 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Streptococcus iniae vaccine

Similar Documents

Publication Publication Date Title
AUPQ879000A0 (en) Mortar composition and method
AU2001249967A1 (en) Composition and methods for tissue preservation
AU2001219651A1 (en) Mulch composition and method
AUPR510001A0 (en) Formulation and method
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU4163402A (en) Composition and method
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001243394A1 (en) Compounds and methods
AU2001295672A1 (en) Vaccine composition and stabilisation method
AU2001233932A1 (en) Method and composition
AU9567201A (en) Vaccine composition and stabilisation method
AUPQ872300A0 (en) Compounds and methods
AU2001233086A1 (en) Ceramidase compositions and methods based thereon
AU2001278951A1 (en) Compounds and methods
AU2001261317A1 (en) Immunostimulant compositions and associated methods
AU2001252741A1 (en) Pharmaceutical composition containing itraconazole with gastric ph-independentlyimproved solubility and preparation method thereof
AU2001234616A1 (en) Vaccine composition, process and methods
AU2002239775A1 (en) Chemical-library composition and method
AU2002256556A1 (en) Sea-trosy and related methods
AU2002235277A1 (en) Compounds and methods
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
AU2001249194A1 (en) Immunokine composition and method
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AUPQ876400A0 (en) Compositions and method of using them